[Latest] Global Catalyst Market Size/Share Worth USD 45.8 Billion by 2033 at a 4.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 17, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, April 17, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Catalyst Market Size, Trends and Insights By Raw Material (Chemical Compounds,...
Blue Biofuels Initiates Engineering and Design for Their CTS Commercial Plant Positioned to Produce Ethanol from Cellulosic Materials
April 16, 2024 08:00 ET
|
Blue Biofuels, Inc.
PALM BEACH GARDENS, FL, April 16, 2024 (GLOBE NEWSWIRE) -- Blue Biofuels, Inc. (OTCQB: BIOF). In a recent development, Blue Biofuels Inc. (“BIOF”) proudly announces the commencement of an FEL...
Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals
October 26, 2023 15:19 ET
|
Catalyst Pharmaceuticals, Inc.
AGAMREE® Indicated for the Treatment of Duchenne Muscular Dystrophy for Patients Aged Two Years and Older Catalyst Holds the Exclusive North American License to Commercialize AGAMREE (vamorolone) for...
Catalyst Pharmaceuticals Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE®
October 13, 2023 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
The sNDA Seeks to Increase the Indicated Maximum Daily Dose for FIRDAPSE to 100mg for the Treatment of Lambert-Eaton Myasthenic Syndrome U.S. FDA Assigned Target Action Date of June 4, 2024 CORAL...
Ruthenium Tetroxide Market revenue to reach USD 2 Billion by 2035, says Research Nester
September 13, 2023 07:52 ET
|
Research Nester
New York, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The global ruthenium tetroxide market is estimated to grow at a CAGR of ~9% over the forecast period. The market is estimated to garner a revenue of ~USD...
Emission Control Catalyst for Marine Market to Experience Significant Growth CAGR of 6.3% - Market Report by RationalStat
August 31, 2023 10:30 ET
|
Rationalstat LLC
Wilmington, Delaware, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Global Emission Control Catalyst for Marine Market is valued at US$ 878.3 million in 2022 and is expected to grow at a significant CAGR of...
Catalyst Market to Surpass 48.9 Billion by 2030 Drives Due to the Increasing Demand from the Automobile Industry
August 23, 2023 10:45 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford,USA, Aug. 23, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, there is a growing demand for catalysts that enable the conversion of bio-derived feedstock into industrially relevant...
Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update
August 09, 2023 16:17 ET
|
Catalyst Pharmaceuticals, Inc.
Achieved Record Q2 2023 Total Net Revenues of $99.6 MillionAchieved FIRDAPSE® 2023 Second Quarter Net Revenues of $64.9 Million, a 22% Increase YOYAchieved 2023 Second Quarter GAAP EPS Diluted of...
Catalyst Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 9, 2023
July 24, 2023 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., July 24, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing,...
Catalyst Pharmaceuticals to License North American Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
June 20, 2023 06:00 ET
|
Catalyst Pharmaceuticals, Inc.
Vamorolone is Currently Under Review with the FDA (PDUFA Date of October 26, 2023) for the Treatment of Duchenne Muscular Dystrophy, a Rare Neuromuscular Disease FDA has Granted Fast Track and Orphan...